Navidea Biopharmaceuticals (NAVB) is one of the most attractive short opportunities we have seen in some time. The company resubmitted its long-awaited drug candidate, Lymphoseek, to the FDA on October 31, 2012. Any “emotional” pop in NAVB’s share price that […]
National Graphite (OTC BB:NGRC) – The company completed a reverse merger in May 2012. The company is an exploration-stage company that engages in the acquisition, exploration, and development of mineral properties. It primarily explores for graphite, gold, silver and precious […]
Do you still think SAIC filings do not matter? How about the SAT documents that are not accessible to independent third parties such as auditors? Think again: It is a Game Changer! SAIC and SAT filings matter: Deloitte finally chose […]